Skip to main content
. 2015 Apr 22;79(5):809–819. doi: 10.1111/bcp.12550

Figure 5.

Figure 5

Simulation of pharmacokinetic model for repeated intermittent dosing regimen (50 mg once daily) (A) and continuous dosing regimen (37.5 mg once daily) (B) (n = 1000). The lines represent the median concentration; the areas represent 25th-75th percentile intervals. The dark grey shows concentration-time profile of sunitinib; the light grey shows SU12662. Inline graphic, median sunitinib; Inline graphic, median SU12662; Inline graphic, 25th-75th percentile sunitinib; Inline graphic25th-75th percentile SU12662